AI & Software Platforms

A new report on AI in the energy sector reveals a critical truth for medicine: general-purpose AI is not ready for high-stakes decisions without human experts.

Accenture is training 30,000 pros on Anthropic's Claude AI, tackling the biggest barrier to enterprise AI: moving from costly experiments to real value.

A partnership between ZEDEDA and Sonny's Enterprises reveals how edge orchestration is transforming traditional industry and creating a blueprint for the future.

One agency's breakout year reveals a critical lesson: strategic AI adoption is no longer optional. Discover the framework for moving beyond hype to ROI.

Target RWE's strategic hire of NoviSci co-founder Alan Brookhart signals a major push to master regulatory-grade real-world evidence. What does this mean?

Facing a fiscal crunch, San Diego County's move to a cloud-based budget system offers a model for data-driven efficiency and public service reform.

PERIOD. appoints Jennifer Herrera as its new ED. How will her background in national advocacy and grassroots organizing reshape the fight for menstrual equity?

OutSystems' #1 G2 ranking isn't just an award; it signals a seismic shift where AI-powered low-code and user satisfaction are the new currencies.

Groundbreaking lymphoma data and a strategic acquisition position Natera to dominate the liquid biopsy market, challenging old standards and creating new value.

Once mired in debt, Castellum has secured over $170M in prime contracts, signaling a dramatic resurgence in the competitive federal defense market.

A quiet investment in a communication platform is making a loud statement about the future of work and education. Here’s why it matters for your brand.

A new lab system combines speed, multiplexing, and regulatory trust, promising to accelerate drug development and deepen our biological understanding.

How the world's largest Catholic media network leveraged its global infrastructure to turn a grassroots prayer event into a worldwide phenomenon.

A new alliance explores how inanimate microbes, or postbiotics, could become a novel weapon in oncology, starting with breast cancer research.

Ashika Investment Managers launches a fund to capture India's next growth wave. Can its disciplined, data-driven strategy unlock value in a volatile market?

BingX aims to democratize crypto trading with a new partner, but our investigation reveals Trade4Me is unregulated and flagged for potential fraud.

A landmark deal for two Airbus A321neos signals more than fleet expansion; it's a strategic play to turn Tashkent into the next major East-West air hub.

As restaurants face economic headwinds, a new AI platform is empowering servers, enhancing guest experience, and promising to double bottom-line profits.

NUS scientists unveil a microneedle patch for plants, slashing waste and boosting growth. A new investment frontier in high-end, sustainable agriculture.

For patients with slow-growing lymphoma, "watch-and-wait" can be agonizing. A novel immunotherapy is showing promise in replacing anxiety with action.